Total Live Articles: 409

Fungal Skin Infection (Tinea)

NICE CKS Fungal skin infection – scalp. Last revised: Feb 2025.

NICE CKS Fungal skin infection – body and groin. Last revised: Jul 2023.

NICE CKS Fungal skin infection – foot. Last revised: Jun 2023.

Fungal Skin Infection (Tinea)

Fungal skin infections, also known as tinea or ringworm, are superficial dermatophyte infections affecting keratinised tissues such as the skin, scalp, hair and feet.

This updated UKMLA guide to fungal skin infection is based on NICE CKS, which covers tinea capitis, tinea corporis, tinea cruris and tinea pedis, including risk factors, diagnosis, and management.

Management Overview

The choice of antifungal across the 3 fungal skin infections is similar but not the same:

  • Scalp infection
    • 1st line: oral antifungal (terbinafine or griseofulvin)
  • Body + groin + foot (Athlete’s foot) infection shares the same management:
    • 1st line: topical antifungal (terbinafine or imidazole)
    • Oral antifungal (1st line: terbinafine) reserved for severe / extensive disease

Scalp Infection (Tinea Capitis)

Fungal infection of the scalp is also known as tinea capitis or scalp ringworm.

Causes and Risk Factors

Most commonly caused by a dermatophyte:

  • Trichophyton tonsurans (caused by human-to-human spread)
  • Microsporum canis (caused by animal-to-human spread)

Risk factors:

  • Most commonly affects pre-pubertal children (peak incidence 3-7 y/o)
  • More common in Afro-Caribbean children
  • Hot, humid climates

Clinical Features

Non-inflammatory involvement is more common:

  • Scaling and itching of the scalp
  • Patchy / circular alopecia (hair loss)
    • Singular or multiple
    • Typically non-scarring
    • Usually asymmetrical

Inflammatory involvement is less common but more severe:

  • Erythema, scattered pustules, crusting
  • Kerion (a painful pustular boggy mass)
  • Permanent, scarring alopecia
  • Lymphadenopathy (usually post-auricular and cervical)

Secondary bacterial infection can also occur.

Investigation and Diagnosis

Dermoscopy is a helpful non-invasive method to help diagnose tinea

Test of choice: skin and hair samples for fungal microscopy and culture

Management

Referral Criteria

  • Suspected kerion → urgent referral
  • Unsuccessful treatment in primary care
  • Severe / extensive / recurrent infection
  • Immunocompromised patients

General Management / Self-Care Advice

Self-management:

  • Soften any surface crusts (e.g. moistened dressings), then gently tease away

Measures to prevent spread and transmission:

  • Discard / disinfect objects that can transmit fungal spores (e.g. hats, scarves, hairbrushes, combs, pillows, blankets, scissors)
  • Do not share towels, and wash frequently
  • If household pet is the suspected source, assess and treat by a vet

Antifungal Treatment

Indications to treat Practically speaking, almost all patients require treatment

Specific indications to treat (ANY):

  • Strong clinical suspicion before mycology results are back
  • +ve microscopy or culture of the skin and hair
  • -ve mycology but suggestive clinical features (but arrange repeat skin and hair sampling)
Choice of antifungal 1st line: oral antifungal (terbinafine or griseofulvin) +/- topical antifungal (e.g. ketoconazole shampoo, imidazole cream)

  • Blind treatment (before culture results are available)
    • If person lives in urban areaterbinafine for 4 weeks
    • If person lives in rural areagriseofulvin for 4-8 weeks
  • Mycology guided treatment (adjust treatment accordingly)
    • If Trichophyton tonsuransterbinafine
    • If Microsporum species → griseofulvin

2nd line antifungal: oral itraconazole

Follow up Review the patient 4-8 weeks after completing oral antifungal therapy.

If signs of persistent / recurrent infection, or hair regrowth do not occur → repeat skin and hair sampling for fungal microscopy and culture.

Body and Groin Infection (Tinea Corporis and Tinea Cruris)

Fungal infection of the body is also known as ‘tinea corporis’ or ‘ringworm’, and fungal infection of the groin is also known as ‘tinea cruris’ or ‘jock itch’

Causes and Risk Factors

Fungal body infection is usually caused by the dermatophyte Trichophyton rubrum or Trichophyton interdigitale.

Fungal groin infection is usually caused by autoinoculation from dermatophyte infection of the hands, feet, or nails caused by Trichophyton rubrum, Trichophyton interdigitale.

Risk factors:

  • Hot, humid climates
  • Working in high-temperature environments
  • Tight-fitting clothing
  • Obesity
  • Hyperhidrosis
  • Immunocompromised

Clinical Features

Body infection (tinea corporis) Affected areas will be itchy and scaly

Appearance:

  • Single or multiple red or pink, ring-shaped patches of varying sizes (usually 1–5 cm)
  • Classically, with a red scaly edge and central clearing
  • Usually asymmetrical
  • Larger lesions may coalesce

More rarely, numerous overlapping concentric circles (tinea imbricate) or herpetiform subcorneal vesicles or pustules (bullous tinea corporis)

Groin infection (tinea cruris) Most commonly affect the inguinal folds and proximal medial thigh

  • Perianal skin, buttocks, and above the waistline may also be affected
  • The penis and scrotum are often spared in males

Affected areas will be itchy and scaly

Appearance:

  • Red / red-brown
  • Flat or slightly raised plaques with active borders (+/- pustules or vesicles)
  • No central clearing
  • The classic scaly edge may be absent (due to the moisture in flexures)

Tinea incognito

Occurs due to inappropriate use of topical corticosteroid (often due to misdiagnosis or self-medication), leading to extensive spread of fungal infection and change in morphology of the lesion

Possible features:

  • Bizarre-shaped lesions
  • Loss or modification of the active erythematous edge
  • Loss of central clearing with eczematous areas within lesions
  • Appearance of double edges or multiple rings

AVOID using topical corticosteroids in tinea.

Investigation and Diagnosis

Test of choice: skin samples for fungal microscopy and culture

Management

General Management / Self-Care Advice

Self management:

  • Wear loose-fitting clothes made of cotton or material designed to keep moisture away from the skin
  • Wash affected skin daily + dry the skin after washing (esp. in the skin folds)
  • Avoid scratching affected skin (as this may spread the infection to other sites)

Measures to prevent spread and transmission:

  • Do not share towels, and wash frequently
  • Wash clothes and bed linen frequently

If a child is affected, it is NOT necessary to exclude them from school or nursery

Antifungal Treatment

Mild AND non-extensive disease 1st line: topical antifungal cream

  • Terbinafine cream (only if >12 y/o), or
  • Imidazole (e.g. clotrimazole, miconazole, econazole) (for all ages)

Consider a mildly potent topical corticosteroid (e.g. hydrocortisone 1%) if there is associated marked inflammation

Severe OR extensive disease Consider oral antifungal

  • 1st line: terbinafine
  • 2nd line: itraconazole / griseofulvin

In children, 1st line is topical imidazole.

Topical terbinafine cream is NOT licensed in those <12 y/o

Foot Infection (Tinea Pedis)

Fungal infection of the foot is also known as ‘athlete’s foot’ or ‘tinea pedis’.

Causes and Risk Factors

Interdigital tinea pedis is most commonly caused by the dermatophyte Trichophyton rubrum

Risk factors:

  • Hot, humid climates
  • Working in high-temperature environments
  • Wearing occlusive footwear (e.g. athletes, miners, soldiers)
  • Hyperhidrosis
  • Walking on contaminated floor surfaces (e.g. communal shower facilities, swimming pools, saunas)
  • Immunocompromised

The prevalence of fungal foot infection increases with age (peak: 31-60 y/o) and is more common in males

Clinical Features

Typically causes scaly, itchy, or painful skin of the feet

There are different types of tinea pedis:

Interdigital type (most common) White or red, fissured, scaling skin or macerated areas in the interdigital areas

Most commonly affects the lateral interdigital space between the 4th and 5th toes and then spreads medially

Moccasin or dry-type A more diffuse, chronic presentation causing scaling, erythema, and hyperkeratosis of the sole and lateral aspect of the foot

Dorsal foot surface is usually spared

Vesicobullous type An inflammatory variant with hard, tense, small (1–5 mm) vesicles, blisters, bullae, and pustules on an erythematous base, mainly on the arches and soles of the feet

Investigation and Diagnosis

Test of choice: skin samples for fungal microscopy and culture

Management

General Management / Self-Care Advice

Self-management:

  • Foot hygiene
    • Wear well-fitting, non-occlusive footwear that keeps the feet cool and dry
    • Wear a different pair of shoes every 2-3 days
    • Wear cotton, absorbent socks
    • Dry the skin after washing the feet (esp. between the toes)
  • Avoid scratching affected skin (as this may spread the infection to other sites)

Measures to prevent spread and transmission:

  • Replace old footwear which could be contaminated with fungal spores
  • Do not share towels, and wash frequently
  • Wear protective footwear when using communal bathing places, locker rooms, gyms

If a child is affected, it is NOT necessary to exclude them from school or nursery

Antifungal Treatment

Mild AND non-extensive disease 1st line: topical antifungal cream

  • Terbinafine cream (only if >12 y/o), or
  • Imidazole (e.g. clotrimazole, miconazole, econazole) (for all ages)

Consider a mildly potent topical corticosteroid (e.g. hydrocortisone 1%) if there is associated marked inflammation

2nd line options:

  • OTC undecenoic acid cream, or
  • Topical preparations containing tolnaftate
Severe OR extensive disease Consider oral antifungal

  • 1st line: terbinafine
  • 2nd line: itraconazole / griseofulvin

In children, 1st line is topical imidazole.

Topical terbinafine cream is NOT licensed in those <12 y/o

References



Related Articles

Fungal Nail Infection (Onychomycosis)

Atopic Dermatitis (Eczema)

Contact Dermatitis

Psoriasis

Share Your Feedback Below

Disclaimer

We’re actively expanding Guideline Genius to cover the full UKMLA content map. Therefore, you may notice some conditions not uploaded yet, or articles that currently focus on diagnosis and management for now.

We are also continuously reviewing and updating existing content to ensure accuracy and alignment with current guidelines. Some earlier articles are undergoing revision as part of this process. Once all content has been fully reviewed, this will be clearly communicated on the platform.

For updates, follow us on Instagram @guidelinegenius.

We welcome any feedback or suggestions via the anonymous feedback box at the bottom of each article and will do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD

Stay Updated withGuideline Genius

Sign up to be notified when our newsletter launches, covering major guideline updates, article updates, and future UKMLA resources.